Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Microbot Medical Inc (NQ: MBOT )

0.9759 -0.0241 (-2.41%)
Streaming Delayed Price Updated: 3:49 PM EDT, Aug 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 223,843
Open 1.000
Bid (Size) 0.9601 (1)
Ask (Size) 0.9760 (3)
Prev. Close 1.000
Today's Range 0.9110 - 1.010
52wk Range 0.8601 - 2.440
Shares Outstanding 14,398,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system 
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women’s Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial 
From Microbot Medical Inc.
Via GlobeNewswire

Performance

YTD
-26.62%
-26.62%
1 Month
-3.38%
-3.38%
3 Month
+1.66%
+1.66%
6 Month
-24.35%
-24.35%
1 Year
-59.84%
-59.84%

More News

Read More
Looking Into Microbot Medical's Recent Short Interest
Via Benzinga
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Dow Dips Over 300 Points; GameStop Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Crude Oil Down Over 3%; US Construction Spending Falls In May
Via Benzinga
Exposures Fossil Fuels
Why Microbot Medical Stock Is Up
Via Benzinga
Exposures Product Safety
Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May
Via Benzinga
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
From Microbot Medical Inc.
Via GlobeNewswire
MBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024
Via InvestorPlace
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Shares Status Following Recent Geopolitical Events
From Microbot Medical Inc.
Via GlobeNewswire
MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023
Via InvestorPlace
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
From Microbot Medical Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.